The Role of Memory, Routine, and Behavior in Neurology Adherence
For patients living with neurological conditions, missing medication can have immediate and meaningful consequences. Yet adherence remains a persistent challenge across neurology populations.
Many patient support programs assume forgetfulness is the only driver of non-adherence. In neurology, that assumption is often correct; however, understanding why patients forget, when they are most likely to miss doses, and what behaviors precede those lapses is critical to improving long-term persistence.
After analyzing 130+ behavioral signals per patient across millions of managed doses, Medisafe identified predictable patterns that influence whether patients stay engaged with therapy over time. The findings reveal that while memory plays a significant role in neurology adherence, behavioral, environmental, and treatment-related factors strongly influence when and why missed doses occur.
Neurology Adherence Is About More Than Memory
Across neurology patient populations, Medisafe's analysis uncovered several notable trends:
- Adherence rates vary across countries and regions.
- Medication-taking behavior fluctuates throughout the week, with adherence varying by day and time of day.
- Different neurological conditions demonstrate distinct adherence patterns and support needs.
- More than 35% of missed doses occur because patients forget or do not have their medication nearby.
These findings highlight an important reality: forgetfulness is often the outcome, not the cause. By understanding the factors that contribute to missed doses, patient support programs can move beyond generic reminders and deliver more effective engagement.
From Reminders to Meaningful Engagement
Many patient support programs rely on static reminders and generalized outreach. While reminders can be valuable in neurology, they often fail to address the circumstances that lead patients to miss medication in the first place.
A patient managing epilepsy faces different challenges than someone living with Parkinson's disease or multiple sclerosis. Likewise, a patient whose routine changes on weekends requires different support than someone who frequently runs out of medication.
Without visibility into these behavioral patterns, support programs often struggle to intervene before adherence begins to decline.
Turning Behavioral Intelligence Into Better Outcomes
Built on 12+ years of real-world patient behavior data, Medisafe's engagement engine helps pharmaceutical organizations identify adherence risk before missed doses become long-term persistence challenges.
By analyzing therapy-specific behavioral signals, treatment characteristics, and real-world patient activity, Medisafe enables brands to deliver personalized support at the moments when intervention can have the greatest impact.
The result is stronger patient engagement, improved adherence, and greater long-term value across neurology portfolios.
New Insights Into Neurology Patient Behavior
Medisafe's latest neurology adherence analysis explores how geography, daily routines, diagnosis type, and patient behavior influence long-term persistence.
The findings offer pharmaceutical teams practical insights into the drivers of neurology adherence and actionable opportunities to strengthen patient support programs.
